MitoTEMPO mitigates light-induced retinal degeneration and photoreceptor ferroptosis in Abca4-/-Rdh8-/- mice via inactivating the KEAP1/NRF2/HO-1 signaling pathway. Here, ABCA4 is linked to retinal degeneration.